Correction to: Molecular targeted drugs resistance impairs doublestrand break repair and sensitizes ERpositive breast cancer to PARP inhibitors.
Breast Cancer
; 29(1): 185, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34420190
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan